Related Experiment Video
Updated: Aug 13, 2026
11:34
Building Up a High-throughput Screening Platform to Assess the Heterogeneity of HER2 Gene Amplification in Breast Cancers
Published on: December 5, 2017
Scoring nuclear pleomorphism in breast cancer
1Department of Pathology, Glasgow University and North Glasgow University Hospitals NHS Trust, Glasgow, UK.
Histopathology
|September 5, 2001
Summary
Histopathologists show variability in grading breast cancer nuclear pleomorphism, indicating a need for standardized criteria. Specialists tend to assign higher scores than non-specialists.
Area of Science:
- Oncology
- Pathology
- Cancer Research
Background:
- Nuclear grade is a critical component of breast cancer grading, alongside mitotic index and acinus formation.
- Current criteria for assessing nuclear grade lack precise definition, leading to potential inconsistencies in breast cancer assessment.
Purpose of the Study:
- To evaluate the consistency of nuclear grading among histopathologists assessing breast cancer.
- To determine if improved criteria for nuclear grading are necessary to enhance diagnostic accuracy.
Main Methods:
- 100 breast cancer cases were assessed by 17 histopathologists using a 0-100 linear analogue scale for nuclear pleomorphism.
- Scores were converted to nuclear pleomorphism grades (1-3), and inter-observer agreement was analyzed using kappa statistics and median comparisons.
Main Results:
- Moderate to good agreement was observed overall, but significant systematic differences in scoring existed between individual pathologists and the group median.
- Pathologists' scores varied, with some consistently assigning lower grades and others higher grades than the median.
- Specialists were less likely than non-specialists to assign scores significantly lower than the group median, suggesting a tendency for specialists to assign higher pleomorphism scores.
Conclusions:
- Systematic variations in nuclear pleomorphism scoring among pathologists highlight the need for refined grading criteria in breast cancer assessment.
- The findings suggest that improved, standardized criteria for nuclear grading are required to ensure consistent and reliable breast cancer grading.
Related Concept Videos
02:55The Nucleolus
The nucleolus is the most prominent substructure of the nucleus. When it was first discovered, it was considered to be an isolated organelle that forms fibrils and granules. In 1931, the relationship between the nucleolus and chromosomes was first described by Heitz. He observed that the appearance and size of nucleolus varies depending on the stage of the cell cycle. He also noticed constricted regions on different chromosomes clustered together at definite cell cycle stages. These regions,...
02:23Abnormal Proliferation
Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the daughter...
02:07Tumor Progression
Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
01:05Cancer-Critical Genes II: Tumor Suppressor Genes
Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
01:05Cancer-Critical Genes II: Tumor Suppressor Genes
Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...